AAIC’s Curated Round-Up of Publications Related to the 2016 Alzheimer’s Association International Conference (Alzheimer’s Association International Conference / Alzheimer’s and Dementia)

Summary

Not everyone will have been able to attend the Alzheimer’s Association International Conference in Toronto last week. The Alzheimer’s Association AAIC Press Office has been kind enough to provide a curated collection of associated publications, relating to the 2016 Alzheimer’s Association International Conference (AAIC®2016).

Full Text Link

Reference

New reports from the Alzheimer’s Association International Conference® 2016. [Press Release]. [Toronto. Online]: Alzheimer’s Association, July 27th 2016.

The AAIC2016 Special Collection:

Note: Selected articles may be available freely; others will require a suitable Athens password, a journal subscription or payment for access.

Biomarkers and Diagnosis

Weiner, MW. Veitch, DP. Aisen, PS. [et al] (2015). 2014 Update of the Alzheimer’s Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. June 2015, 11(6), e1-e120. Full Text Link.

Aisen, PS. Petersen, RC. Donohue, M. [et al] (2015). Alzheimer’s Disease Neuroimaging Initiative 2 Clinical Core: progress and plans. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. July 2015, 11(7), 734-739. Full Text Link.

Beckett, LA. Donohue, MC. Wang, C. [et al] (2015). The Alzheimer’s Disease Neuroimaging Initiative phase 2: increasing the length, breadth, and depth of our understanding. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. July 2015, 11(7), 823-831. Full Text Link.

Jagust, WJ. Landau, SM. Koeppe, RA. [et al] (2015). The Alzheimer’s Disease Neuroimaging Initiative 2 PET Core: 2015. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. July 2015, 11(7), 757-771. Full Text Link.

Kang, JH. Korecka, M. Figurski, MJ. [et al] (2015). The Alzheimer’s Disease Neuroimaging Initiative 2 Biomarker Core: a review of progress and plans. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. July 2015, 11(7), 772-791. Full Text Link.

Toga, AW. [and] Crawford, KL. (2015). The Alzheimer’s Disease Neuroimaging Initiative informatics core: a decade in review. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. July 2015, 11(7), 832-839. Full Text Link.

Mukherjee, S. Walter, S. Kauwe, JSK. [et al] (2016). Genetically predicted body mass index and Alzheimer’s Disease-related phenotypes in three large samples: Mendelian randomization analyses. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. December 2015, 11(12), 1439-1451. Full Text Link.

Jones-Davis, DM. [and] Buckholtz, N. (2015). The impact of the Alzheimer’s Disease Neuroimaging Initiative 2: what role do public-private partnerships have in pushing the boundaries of clinical and basic science research on Alzheimer’s Disease? Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. July 2015, 11(7), 860-864. Full Text Link.

Weiner, MW. Veitch, DP. Aisen, PS. [et al] (2015). Impact of the Alzheimer’s Disease Neuroimaging Initiative, 2004 to 2014. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. July 2015, 11(7), 865-884. Full Text Link.

Hendrix, JA. Finger, B. Weiner, MW. [et al] (2015). The Worldwide Alzheimer’s Disease Neuroimaging Initiative: an update. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. July 2015, 11(7), 850-859. Full Text Link.

Epidemiology and Economics

Jones, RW. Romeo, R. Trigg, R. [et al] (2015). Dependence in Alzheimer’s Disease and service use costs, quality of life, and caregiver burden: the DADE study. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. March 2015, 11(3), 280-290. Full Text Link.

Leibson, CL. Long, KH. Ransom, JE. [et al] (2015). Direct medical costs and source of cost differences across the spectrum of cognitive decline: a population-based study. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. August 2015, 11(8), 917-932. Full Text Link.

Handels, RLH. Joore, MA. Tran-Duy, A. [et al] (2015). Early cost-utility analysis of general and cerebrospinal fluid-specific Alzheimer’s Disease biomarkers for hypothetical disease-modifying treatment decision in mild cognitive impairment. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. August 2015, 11(8), 896-905. Full Text Link.

Ryan, J. Carrière, I. Carcaillon, L. [et al] (2014). Estrogen receptor polymorphisms and incident dementia: the prospective 3C study. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. January 2014, 10(1), 27-35. Full Text Link.

Chêne, G. Beiser, A. Au, R. [et al] (2015). Gender and incidence of dementia in the Framingham Heart Study from mid-adult life. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. March 2015, 11(3), 310-320. Full Text Link.

Lucca, U. Tettamanti, M. Logroscino, G. [et al] (2015). Prevalence of dementia in the oldest old: the Monzino 80-plus population based study. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. March 2015, 11(3), 258-270.e253. Full Text Link.

Radford, K. Mack, HA. Draper, B. [et al] (2015). Prevalence of dementia in urban and regional Aboriginal Australians. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. March 2015, 11(3), 271-279. Full Text Link.

Jia, J. Wang, F. Wei, C. [et al] (2014). The prevalence of dementia in urban and rural areas of China. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. January 2014, 10(1), 1-9. Full Text Link.

Prevention and Treatments

Vaudano, E. Vannieuwenhuyse, B. Van Der Geyten, S. [et al] (2015). Boosting translational research on Alzheimer’s Disease in Europe: the Innovative Medicine Initiative AD research platform. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. September 2015, 11(9), 1121-1122. Full Text Link.

Olsson, B. Legros, L. Guilhot, F. [et al] (2014). Imatinib treatment and Aβ42 in humans. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. May 2014, 10(5), S374-S380. Full Text Link.

Greig, NH. Tweedie, D. Rachmany, L. [et al] (2014). Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injury. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. January 2014, 10(1), S62-S75. Full Text Link.

Pelletier, A. Barul, C. Féart, C. [et al] (2015). Mediterranean diet and preserved brain structural connectivity in older subjects. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. September 2015, 11(9), 1023-1031. Full Text Link.

Morris, MC. Tangney, CC. Wang, Y. [et al] (2015). MIND diet associated with reduced incidence of Alzheimer’s Disease. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. September 2015, 11(9), 1007-1014. Full Text Link.

Morris, MC. Tangney, CC. Wang, Y. [et al] (2015). MIND diet slows cognitive decline with aging. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. September 2015, 11(9), 1015-1022. Full Text Link.

Talbot, K. [and] Wang, HY. (2014). The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer’s Disease. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. January 2014, 10(1), S12-S25. Full Text Link.

Schneider, LS. (2014). Rethinking the Food and Drug Administration’s 2013 guidance on developing drugs for early-stage Alzheimer’s Disease. Alzheimer’s and Dementia: the Journal of the Alzheimer’s Association. February 2014, 10(2), 247-250. Full Text Link.

Advertisements

About Dementia and Elderly Care News

Dementia and Elderly Care News. Wolverhampton Medical Institute: WMI. (jh)
This entry was posted in Charitable Bodies, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Management of Condition, Mental Health, Models of Dementia Care, Non-Pharmacological Treatments, Person-Centred Care, Pharmacological Treatments, Quick Insights, Universal Interest and tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s